1. Home
  2. TYRA vs VREX Comparison

TYRA vs VREX Comparison

Compare TYRA & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • VREX
  • Stock Information
  • Founded
  • TYRA 2018
  • VREX 2016
  • Country
  • TYRA United States
  • VREX United States
  • Employees
  • TYRA 38
  • VREX N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • TYRA Health Care
  • VREX Technology
  • Exchange
  • TYRA Nasdaq
  • VREX Nasdaq
  • Market Cap
  • TYRA 666.4M
  • VREX 576.8M
  • IPO Year
  • TYRA 2021
  • VREX N/A
  • Fundamental
  • Price
  • TYRA $13.17
  • VREX $12.64
  • Analyst Decision
  • TYRA Strong Buy
  • VREX Strong Buy
  • Analyst Count
  • TYRA 6
  • VREX 2
  • Target Price
  • TYRA $30.50
  • VREX $22.50
  • AVG Volume (30 Days)
  • TYRA 247.2K
  • VREX 597.0K
  • Earning Date
  • TYRA 03-18-2025
  • VREX 02-06-2025
  • Dividend Yield
  • TYRA N/A
  • VREX N/A
  • EPS Growth
  • TYRA N/A
  • VREX N/A
  • EPS
  • TYRA N/A
  • VREX N/A
  • Revenue
  • TYRA N/A
  • VREX $820,800,000.00
  • Revenue This Year
  • TYRA N/A
  • VREX $4.03
  • Revenue Next Year
  • TYRA N/A
  • VREX $3.32
  • P/E Ratio
  • TYRA N/A
  • VREX N/A
  • Revenue Growth
  • TYRA N/A
  • VREX N/A
  • 52 Week Low
  • TYRA $11.89
  • VREX $10.19
  • 52 Week High
  • TYRA $29.60
  • VREX $18.30
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 43.64
  • VREX 40.62
  • Support Level
  • TYRA $12.27
  • VREX $13.01
  • Resistance Level
  • TYRA $13.79
  • VREX $13.86
  • Average True Range (ATR)
  • TYRA 0.71
  • VREX 0.76
  • MACD
  • TYRA 0.03
  • VREX -0.08
  • Stochastic Oscillator
  • TYRA 51.09
  • VREX 22.95

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Share on Social Networks: